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The immunoglobulin profiles of 126 Nigerian children infected with Plasmodium falciparum in their 
peripheral blood were investigated. The mean malarial parasitaemia was 4699.17 ± 3695.2 µl. The mean 
immunoglobulin profile of these infected children were 2.68 ± 0.019 mg/dl for IgA, 0.031 ± 0.01 mg/dl for 
IgD, 1358.29 ± 123.57 ng/dl for IgE, 19.09 ± 1.27 mg/dl for IgG and 2.80 ± 0.57 mg/dl for IgM. The 
relationship between the IgD and IgE were positively correlated with the ages of the volunteers at (r = 
0.89 and r = 0.97, respectively). The levels of IgA, IgG and IgM were negatively correlated with the ages 
of the infected children (r = -0.96, r = -0.99 and r = -0.85, respectively).  The relationship between the 
level of parasitaemia and IgA, IgD and IgM were negatively correlated (r = -0.82, r = -0.84 and r = -0.82, 
respectively).  IgG correlated positively with the level of malarial parasitaemia (r = 0.99). We deduce that 
high IgE and low levels of IgA and IgM are associated with the high risk of P. falciparum malaria attack 
in our community. 
 





Malaria is ranked as a major tropical disease in Africa 
responsible for cases of morbidity especially in children. 
Among the children, those under 5 years of age are more 
vulnerable (WHO, 2000). The wide spectrum of clinical 
manifestations of malaria is due to the asexual blood 
stages of Plasmodium falciparum and attempts have con-
sequently been made to identify asexual stage antigens 
that may be of importance in the development of protec-
tive immunity to the disease (Warrell, 1993). Of the 
antigens elaborated, the P. falciparum  merozoite surface 
protein 1 (PfMSP1) is widely investigated (Dodoo et al., 
1999; Pitabut et al., 2007; Scopel et al., 2005; Omosun et 
al., 2005). The result from this investigation implicates 
PFMSP1 as a vaccine candidate. 
Globally, the investigation on the humoral immune res-
ponses in P. falciparum infection exist (Desowitz  1989; 
Taylor et al., 1998; Aucan et al., 2002; Cavanagh et al., 
2001, Diallo et al., 2002; Callisano et al.,  2003).  For 
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malaria endemic regions develop elevated levels of IgE 
(Desowitz, 1989).  
In Nigeria, there is dearth of information on humoral 
immune responses to P. falciparum infection despite the 
impact of this parasitic infection on our health. The only 
existing information (Omosun et al., 2005) reports on the 
relationship between Anti-MSP-119 and IgG among some 
Nigerians in a different location and of different ethnic 
group. In this communication, we therefore evaluate the 
immunological status of some children infected with P. 
falciparum in a different locality in Nigeria. We esta-
blished the relationship between their ages, intensity of 
infection and the immunoglobulin classes. 
 
 
MATERIALS AND METHODS 
 
The study was conducted in Ekpoma, head quarters of Esan West 
Local government area of Nigeria. Ekpoma has an estimated 
population of 2 million and lies between latitude 6° 4′N and 
longitude 6° 4′E. It is an urban university town. There is a rainy 
season period of April to October which is followed by a dry season 
of November to March. Malaria transmission is perennial but 
highest during the rainy season.  









One hundred and twenty six children who attended Faith Dome 
Medical centre, Ekpoma, Nigeria and had malaria attack based on 
P. falciparum parasitaemia in their thick blood smears stained by 
Giemsa stain participated in the study. The malaria parasitaemia 
was categorized as mild (<1000 asexual form of parasite /µl), 
moderate (1000 – 10,000 parasite/µl) and severe (>10,000 
parasite/µl) as described earlier (Egwunyenga et al., 2004). They 
also had fever (axillary temperature of > 37.5°C) and clinical symp-
toms such as headache, vomiting, diarrhea, prostration, respiratory 
distress and other symptoms and signs of severe malaria as 
documented in WHO (2000). They were recruited after informed 
parental consent was obtained following thorough explanation of all 
procedures and the objectives of investigation. Ethical permission 
was obtained from Faith Dome Medical centre, Ekpoma and the 
Edo State ministry of Health, Benin City, Nigeria. Children with 
other detectable diseases such as HIV/AIDS, sickle cell anaemia, 
intestinal parasitic infections, and viral hepatitis B were excluded in 
this investigation using standard procedures and kits. 
The Recombinant P. falciparum merozoite surface protein 1 
(PfMSP119) was the antigen used in this investigation. The secreted 
recombinant protein PfMSP119 was purified as previously described 
(Egan et al., 1995; Dodoo et al., 1999). Venous blood were obtain-
ed from the P. falciparum infected volunteers and the 30 control 
subjects. Their sera were separated by centrifugation using 
standard procedure. These were subjected to modified radial immu-
nodiffusion assay of Mancini et al. (1965) for determination of the 
levels of immunoglobulins.  
The data obtained in our study were subjected to statistical 





The immunoglobulin profile of P. falciparum infected 
volunteers and their control subjects according to their 
age groups in years are presented in Table 1. The mean 
immunoglobulin status were 2.68 ± 0.019 mg/dl for IgA, 
0.031 ± 0.01 mg/dl for IgD, 1358.29 ± 123.57 ng/dl for 
IgE, 19.09 ± 1.27 mg/dl for IgG and 2.80 ± 0.57 mg/dl for 
IgM. These mean immunoglobulin of the infected volun-
teers were lower than their control subjects (IgA = 210.0 
± 11.5 mg/dl, IgD = 0.12 ± 0.04 mg/dl, IgG = 1205.15 ± 
13.53 mg/dl, IgM = 110.02 ± 16.7 mg/dl) except IgE 
where the control subjects had 0 ng/dl. The mean 
malarial parasitaemia was 4699.17 ± 2985.22 µl. The IgD 
and IgE profile showed positive correlation with the ages 
of the P. falciparum infected volunteers (r = 0.89 and r = 
0.97, respectively). The relationship between IgA, IgG 
and IgM were negatively correlated with the ages of the 
P. falciparum infected volunteers (r = -0.96, r = -0.99 and 
r = -0.85, respectively). The children within 1 - 5 years of 
age had the highest IgM, IgD and IgA as 3.18 ± 1.31 
mg/dl, 20.62 ± 3.21 mg/dl and 2.80 ± 1.06 mg/dl, respec-
tively. Conversely the highest IgD (0.041 ± 0.03 mg/dl) 
and IgE (1507.33 ± 447.07 ng/dl) occurred among the 
volunteers between 11 - 15 age group in years. 
Table 2 showed the immunoglobulin profile of the P. 
falciparum according to the 3 levels of parasitaemia as 
mild (521.15 ± 95.41), moderate (3432.0 ± 1051.71) and 
severe (10,150 ± 1839.52). The relationship between 
total IgG and the levels of parasitaemia was positively 
correlated (r = 0.99). IgM, IgD and IgA had negative 
correlation with the intensities of the malarial parasitae-





The data on the malarial parasitaemia revealed that 
children within 1 – 5 years of age had the highest level of 
parasitaemia than the older children. This pattern of 
infection is expected considering the fact that these 
children get exposed repeatedly very early in life in our 
environment where adequate malarial control measure is 
lacking. Also severe malaria is seen most frequently in 
children less than 5 years of age, after which age depen-
dent clinical immunity sets in. These observation accords 
earlier reports (WHO, 2000; Idro et al., 2005). 
We found a high level of IgE responses among the P. 
falciparum infected volunteers than their control subjects 
and a correlation of this IgE antibody with age which we 
consider immunologically significant as it supports the 
earlier deduction that it may play a role in protection 
against malaria (Calissano et al., 2003). This pattern of 
elevation of IgE and its importance in plasmodial infecton 
had been documented earlier (Perlmann et al., 1994; 
Daurte et al., 2007; Desowitz 1989; Maeno et al., 1993). 
An important observation recorded in our present inves-
tigation is the lowest IgE status found among volunteers 
with severe malaria. This denotes that the lower IgE 
responses are associated with severity of infection. Also 
we found the IgE antibodies responses protective at the 
higher values which occurred among the older children 
with mild and uncomplicated malaria.  These  patterns  of  
















1-5 3.18±1.31 0.014±0.015 1204.75±402.09 20.62±3.21 2.80±1.60 9560.4±2413.8 50 (39.7) 
6-10 3.22±1.32 0.039±0.04 1362.78±394.11 19.13±1.46 2.64±1.04 3913.1±817.3 42 (26.9) 
11-15 2.00±1.52 0.041±0.03 1507.33±447.07 17.52±1.53 2.59±0.73 624.0±56.6 34 (26.9) 
Mean infected 2.80±0.57 0.031±0.01 1356.95±16.28 19.09±1.27 2.68±0.09 4699.17±3695.2 126 
Mean for 
control 
110.02±16.7 0.12±0.04 - 1205.15±13.53 210.01±11.5 - - 

















presentation corroborates the documentation of 
Callisanno et al. (2003) which reported that anti malarial 
IgE may well be protective but may also contribute to the 
severity of the disease. 
We observed a positive correlation between the level of 
malarial parasitaemia and total IgG profile. Also we 
reported the highest total IgG among the children within 1 
– 5 years who had the highest parasite load and this 
implicates high IgG to be associated with severity of 
malaria in our locality. These observations appears to 
deviates from the assertion that IgG appears to play a 
role in protection against malarial diseases (Cohen et al., 
1962; McGregor et al., 1963). The negative correlation 
between IgG and severity of infection accords the report 
of (Marsh, 1992; Miller et al., 1994). 
The prevalence of antibodies namely IgA, IgG, and IgM 
were depleted in the P. falciparum infected volunteers 
compared to their control counterparts. This pattern of 
low prevalence had been documented in Gambia and 
Sierra Leone (Egan et al., 1996). The low antibodies 
prevalence reported in our present study may be in part 
be due to the short half life of anti-PfMP19 antigens which 
are mainly found after clinical episodes (Branch et al., 
1998; Früh et al., 1991; Cavanagh et al., 1998) and low 
immunogenicity or lack of adequate T cell help for 
antibody production in these infected children (Egan et 





The inadequate immune responses associated with these 
antibodies (IgA, IgG, and IgM) indicate that they do not 
provide sufficient protection in these children with P. 
falciparum infection. Therefore, these low IgA, IgG and 
IgM and high level of IgE antibodies are associated with 
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